Stage FocusSeed, Series A, Series B+
GeographyUK, US
TypeVC
Last Activity2026
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Epidarex is a transatlantic venture capital firm investing in early-stage life science and health technology companies in under-ventured research hubs across the UK and US, including Edinburgh, Glasgow, Cambridge, and London on one side and Louisville, St. Louis, Baltimore, New York, and Boston on the other. It is now deploying its fourth fund, Epidarex Capital IV, and is led by managing partners ...
Notable Investments
D
Dunad TherapeuticsC
Curve TherapeuticsC
Clyde BiosciencesL
Leucid BioE
EpsilogenH
Harpoon MedicalK
Kynos TherapeuticsE
Enterprise TherapeuticsE
Edinburgh Molecular ImagingK
Kodikaz Therapeutic SolutionsL
Lario TherapeuticsH
Harness TherapeuticsSimilar Funds
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAIMedtechSeedSeries A
BC
Boundary Capital
Northampton, United Kingdom
Pure DeepTechBiotechMedtechAdvanced MaterialsSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A